References
- Clements J. M., Craig S., Gearing A. J. H., Hunter M. J., Heyworth C. M., Dexter T. M., Lord B. I. Biological and structural properties of MIP-1α expressed in yeast. Cytokine 1992; 4: 76–82
- Dunlop D. J., Wright E. G., Lorimore S., Graham G. J., Holyoake T., Kerr D. J., Wolpe S. D., Pragnell I. B. Demonstration of stem cell inhibition and myeloproliferative effects of SCI/rhMIP-1α in vivo. Blood 1992; 79: 2221–2225
- Eaves C. J., Cashman J. D., Wolpe S. D., Eaves A. C. Unresponsiveness of primitive chronic myeloid leukaemia cells to macrophage inflammatory protein-1α, an inhibitor of primitive normal hematopoietic cells. Proc. Natl Acad. Sci. USA 1993; 90: 12015–12019
- Gidali J., Lajtha L. G. Regulation of haemopoietic stem cell turnover in partially irradiated mice. Cell Tissue Kinet. 1972; 5: 147–157
- Graham G. J., Wright E. G., Hewick R., Wolpe S. D., Wilkie N. M., Donaldson D., Lorimore S., Pragnell I. B. Identification and characterisation of an inhibitor of haemopoietic stem cell proliferation. Nature 1990; 344: 442–444
- Keller J. R., Bartelmez S. H., Sitinicka E., Ruscetti F. W., Ortiz M., Gooya J. M., Jacobsen S. E. W. Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood 1994; 84: 2175–2181
- Lord B. I. In vivo assays for multipotential and marrow repopulating cells. Haemopoiesis; A Practical Approach, N. G. Testa, G. Molineux. IRL Press, Oxford, New York, Tokyo 1993; 1–20
- Lord B. I., Dexter T. M., Clements J. M, Hunter M. J., Gearing A. H. Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 1992; 79: 2605–2609
- Lord B. I., Liu F.-L., Pojda Z., Spooncer E. Inhibitor of haemopoietic CFU-S proliferation: assays, production sources and regulatory mechanisms. The Inhibitors of Hematopoiesis, A. Najman, et al. John Libbey, London & Paris 1987; 162: 227–240, Colloque Inserm
- Lord B. I., Mori K. J., Wright E. G., Lajtha L. G. An inhibitor of stem cell proliferation innormal bone marrow. Brit. J. Haematol 1976; 34: 441–445
- Lord B. I., Woolford L. B. Proliferation of spleen colony forming units (CFU-S8, CFU-S13) and cells with marrow repopulating ability. Stem Cells 1993; 11: 212–217
- Lord B. I., Wright E. G. Sources of haemopoietic stem cell proliferation regulatiors: stimulators and inhibitors. Blood Cells 1980; 6: 581–593
- Lord B. I., Wright E. G., Lajtha L. G. Actions of the haemopoietic stem cell proliferation inhibitor. Biochem. Pharmacol 1979; 28: 1843–1848
- Maze R., Sherry B., Kwon B. S., Cerami A., Broxmeyer H. E. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1α. J. Immunol. 1992; 149: 1004–1009
- Quesniaux V. F. J., Graham G. J., Pragnell I., Donaldson D., Wolpe S. D., Iscove N. N., Fagg B. Use of 5 Fluorouracil to analyze the effect of marcophage inflammatory protein-lα on long-term reconstituting stem cells in vivo. Blood 1993; 81: 1497–1504
- Schofield R., Lord B. I. 3H-Thymidine “suicide” and the CFU-S population. IRCS Med. Sci. 1984; 12: 779–780
- Till J. E. Overlap error in counts of splenic colonies. Ser Haematologica 1972; V: 5–14
- Toksoz D., Dexter T. M., Lord B. I., Wright E. G., Lajtha L. G. The regulation of haemopoiesis in long-term bone marrow cultures. II. Stimulation and inhibition of stem cell proliferation. Blood 1980; 55: 931–936
- Verfaillie C. M., Catanzarro P. M., Li W. N. Macrophage-inflammatory protein 1 alpha, interleuking 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least 8 weeks in vitro. J. Exp. Med. 1994; 179: 643–649
- Wright E. G., Lorimore S. A., Lord B. I. Effect of haemopoietic stem cell proliferation regulators on early and the late spleen colony-forming cels. Cell Tissue Kinet. 1985; 18: 193–199